WuXi Biologics hits 6-week high on confidence in delivering FY26 guidance
01/06/2026 04:51
BUZZ-WuXi Biologics hits 6-week high on confidence in delivering FY26 guidance ** Shares of WuXi Biologics (Cayman) Inc 2269.HK climb 3.4% to HK$35.46, their highest level since April 22
** Stock on track for the biggest one-day pct gain since May 26 in the second rising session
** Chinese biologics discovery, development, and manufacturing group said it added 69 new projects in the January-April period, with 2/3 of the new projects coming from the U.S. and EU
** Confident in delivering FY26 guidance and maintains its expectation of reported revenue growth of 13%–17% y/y for the year, and the company initiated a new $400 million share repurchase program - co
** YTD, stock up 8.9%, while Hang Seng Biotech Index .HSBIO down 6.2%
(Reporting by Donny Kwok)
Recent news on WuXi Biologics (Cayman)
See all newsWuXi Biologics hits 6-week high on confidence in delivering FY26 guidance
Brief: Wuxi Biologics Adds 69 Projects In Jan-April, Maintains Expected Revenue Growth
Viridian Therapeutics signs manufacturing deal with WuXi Biologics for thyroid eye disease drug
WuXi Biologics climbs most in six weeks on share repurchase plan
Brief: Wuxi Biologics To Repurchase Shares Up To Us$400 Million In Open Market